3-(3-PYRIMIDIN-2-YLBENZYL)-1,2,4-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AS MET KINASE INHIBITORS
申请人:Dorsch Dieter
公开号:US20110092498A1
公开(公告)日:2011-04-21
Compounds of the formula (I), in which R
1
, R
2
, R
3
, R
3′
, R
4
have the meanings indicated in Claim
1
, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.
式(I)的化合物中,其中R1、R2、R3、R3'、R4具有权利要求书中指示的含义,是酪氨酸激酶的抑制剂,特别是Met激酶的抑制剂,并可用于治疗肿瘤等疾病。